TECAD Cirurgia Digestiva study materials
TECAD Cirurgia Digestiva study resources

Upper GI Bleeding in a Patient with Cirrhosis: Timing of Endoscopy and Transfusion Strategy

TECAD Cirurgia Digestiva · Put your knowledge to work in context.

All case studies

Upper GI Bleeding in a Patient with Cirrhosis: Timing of Endoscopy and Transfusion Strategy

A 58-year-old man with alcohol-related cirrhosis (Child-Pugh class B, MELD 18) presents with hematemesis and melena. He is confused and disoriented. Vital signs: BP 92/58 mmHg, HR 118 bpm, temperature 36.8°C. Hemoglobin 7.2 g/dL, platelets 88,000/µL, INR 1.8, creatinine 1.3 mg/dL. He received 2 liters of normal saline in the ambulance. The emergency department resident is preparing to intubate for airway protection and wants to know the optimal timing of endoscopy and transfusion targets. The ICU has one available bed and the endoscopy suite is available in 30 minutes. The patient's family asks about the risks of the procedure.

1. What is the most appropriate initial management regarding airway, transfusion, and timing of endoscopy? Provide a rationale for each decision.

Read the worked answer

This patient has a variceal hemorrhage until proven otherwise, given cirrhosis and hemodynamic instability. Airway: He has altered mental status (likely hepatic encephalopathy) and ongoing hematemesis, so endotracheal intubation is indicated before endoscopy to prevent aspiration, especially if he is confused. Transfusion: A restrictive strategy is preferred (target Hb 7–8 g/dL) because over-transfusion increases portal pressure and rebleeding risk. With Hb 7.2 g/dL and active bleeding, he needs blood, but the goal is not to normalize Hb. Fresh frozen plasma and platelets are not routinely given unless there is significant coagulopathy with bleeding, as volume overload can worsen portal hypertension. Timing: Endoscopy should be performed within 12 hours after resuscitation, not necessarily immediate, but in this unstable patient with ongoing bleeding, earlier is better once airway is secured. Vasoactive drugs (octreotide) and prophylactic antibiotics (e.g., ceftriaxone) should be started immediately. The family should be informed that the procedure carries risks of aspiration, worsening encephalopathy, and bleeding, but benefits outweigh risks.

2. If endoscopy reveals large esophageal varices with active spurting, what endoscopic therapy and additional measures are indicated? How would you manage the post-procedure care?

Read the worked answer

Endoscopic variceal ligation (EVL) is the preferred therapy for acute variceal bleeding; sclerotherapy is an alternative if EVL is not feasible. If bleeding is refractory, a temporary balloon tamponade (Sengstaken-Blakemore tube) or covered self-expandable metal stent can be used as a bridge to definitive therapy (TIPS). Additional measures: Continue vasoactive infusion (octreotide) for 3–5 days, complete antibiotic prophylaxis for up to 7 days, and consider early TIPS (within 72 hours) in high-risk patients (Child-Pugh C or B with active bleeding). Post-procedure: Monitor for rebleeding, signs of infection, and encephalopathy. Avoid NSAIDs and maintain PPI if indicated. Nutritional support and lactulose for encephalopathy. The patient should be evaluated for liver transplantation if eligible.